Panacea Life Sciences Holdings, Inc. (PLSH) income statement
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2024, quý kết thúc ngày Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences Holdings, Inc. income statement
Ratios
Latest available, balances at Mar 31, 2024
Profitability, TTM
- Gross margin
- 56.5%
- Operating margin
- -192.2%
- Net margin
- -277.5%
- Return on equity, FY2023
- 153.6%
Financial strength
- Current ratio
- 0.23
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.5%
Valuation
- P/E ratio
- –
- Price to sales
- 0.42
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?